SAI
KYNB

Savvy Advisors Inc’s Kyntra Bio KYNB Stock Holding History

Savvy Advisors Inc’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-823
Closed -$6.38K – 653
2025
Q1 		$6.38K Hold
823
– – ﹤0.01% 517
2024
Q4 		$10.9K Buy
+823
New +$7.65K ﹤0.01% 449

Other funds holding KYNB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Savvy Advisors Inc's KYNB Position: Q2 2025 in Review

Savvy Advisors Inc sold out of Kyntra Bio (KYNB) in Q2 2025, closing a stake of 823 shares — an estimated $6.38K sold.

Savvy Advisors Inc first reported a position in KYNB in Q4 2024 and held it in 2 quarters. The position peaked at $10.9K in Q4 2024. 30 funds tracked by Wall St. Rank hold KYNB as of Q2 2025.

  • Savvy Advisors Inc reported no remaining Kyntra Bio position as of Q2 2025 after selling out during the quarter.
  • Savvy Advisors Inc sold 823 Kyntra Bio shares in Q2 2025, an estimated $6.38K.
  • Savvy Advisors Inc first reported a position in Kyntra Bio in Q4 2024 and held it in 2 quarters.
  • Savvy Advisors Inc's Kyntra Bio position peaked at $10.9K in Q4 2024.
  • 30 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2025.

Based on Savvy Advisors Inc's 13F filing for Q2 2025, filed 4 Aug 2025.